Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg)

Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Cilnidipine and Olmesartan Medoxomil Tablets (10MG+40MG)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Cilnidipine and Olmesartan Medoxomil Tablets (10MG+40MG)
  Each film coated tablet contains:
  Cilnidipine IP………………………………………10mg
  Olmesartan Medoxomil IP……………………….40mg
  Colours: Ferric Oxide Red USP-NF and Titanium
  Dioxide IP

THERAPEUTIC INDICATIONS:

Olmesartan Medoxomil + Chlorthalidone is used in the treatment of Hypertension (high blood pressure). Olmesartan Medoxomil + Chlorthalidone is a combination of two medicines: Olmesartan and chlorthalidone which lower blood pressure effectively. Olmesartan is an angiotensin receptor blocker (ARB).

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.

WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

CAUTION: It is dangerous to take this preparation except under medical supervision.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 25℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg)

Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) are a highly effective combination therapy used for treating hypertension (high blood pressure). Hypertension is a widespread medical condition affecting millions globally and is a major risk factor for cardiovascular diseases, stroke, and kidney disorders.

This combination works through dual mechanisms. Cilnidipine, a calcium channel blocker, relaxes blood vessels, allowing blood to flow more efficiently. Olmesartan Medoxomil, an angiotensin II receptor blocker (ARB), prevents vasoconstriction by blocking the action of angiotensin II. Together, they reduce the heart’s workload, maintain proper blood pressure, and improve overall cardiovascular health.

Globally, the demand for Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) is steadily increasing due to the rise in lifestyle-related hypertension and the need for effective, safe, and reliable anti-hypertensive medications. India, recognized for its advanced pharmaceutical manufacturing capabilities, provides high-quality, cost-effective solutions for international markets.

In-depth Details for Importers, Exporters, and Buyers

Taj Pharma, a top Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) manufacturer in India, offers comprehensive support for international buyers.

✅ Regulatory Documentation Provided

Taj Pharma ensures all regulatory requirements are met, offering:

• WHO-GMP Certification for production quality

• EU-GMP Approval for regulated international markets

• Certificate of Pharmaceutical Product (COPP)

• CTD/ACTD Dossier for regulatory submission

• Free Sale Certificate (FSC) for overseas marketing

• Certificate of Analysis (COA) for each batch

• Stability Data according to ICH guidelines

✅ Custom Packaging & Labeling

• Alu-Alu blister packs, HDPE bottles, and unit-dose packs

• Multi-lingual labeling to comply with international regulations

• Private labeling and customized branding options

• Tamper-evident and export-compliant packaging

✅ Shelf-life, Storage & Dosage Form

• Dosage Form: Tablet

• Strength: 10mg Cilnidipine + 40mg Olmesartan Medoxomil

• Shelf-life: 24–36 months

• Storage: Store below 30°C in a dry place, away from sunlight

✅ Export Certifications

• WHO-GMP certified production facility

• EU-GMP approved for regulated markets

• USFDA-compliant processes

• PIC/S and ICH guideline adherence

✅ Target Countries & Export Markets

Taj Pharma exports Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) to over 70 countries, including:

• Europe: UK, Germany, France, Italy

• Asia-Pacific: Vietnam, Malaysia, Thailand, Philippines

• Africa: Nigeria, Kenya, South Africa, Ghana

• Middle East: UAE, Saudi Arabia, Oman, Iraq

• Latin America: Brazil, Mexico, Chile, Peru

Why is the Most Trusted Manufacturer/Supplier/Exporter

Taj Pharma has established itself as the leading Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) manufacturer in India due to its unwavering focus on quality, affordability, and global compliance.

🌟 State-of-the-Art Manufacturing

• WHO-GMP and EU-GMP-certified facilities in Vapi, Gujarat

• Advanced, automated production lines with minimal contamination

• Dedicated QC and QA teams ensuring uniformity and reliability

🌟 Affordable Pricing & Quality Assurance

• Competitive pricing for bulk buyers

• Compliance with USP, BP, EP, IP pharmacopoeia standards

• Comprehensive quality control from raw material sourcing to finished product

🌟 Global Presence & Supply Chain Support

• International logistics and warehousing capabilities

• Timely delivery to regulated and semi-regulated markets

• Complete support for import/export documentation

🌟 Top 20 Countries Exporting

1. UK

2. Germany

3. France

4. Italy

5. Vietnam

6. Philippines

7. Thailand

8. Malaysia

9. Nigeria

10. Kenya

11. South Africa

12. UAE

13. Saudi Arabia

14. Oman

15. Iraq

16. Brazil

17. Mexico

18. Chile

19. Peru

20. Ghana

Common Side Effects & Safety Information

Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) are generally well-tolerated. Some side effects may include:

• Feeling dizzy or tired

• Headaches, flu-like symptoms, runny/stuffy nose, cough

• Pain in back, bones, or joints

• Nausea, indigestion, or stomach discomfort

• Diarrhea

• Swelling of feet, ankles, legs, or hands (edema)

• Urinary tract infection (UTI)

Important Precautions:

• Olmesartan may cause kidney damage; regular monitoring is essential

• Hyperkalemia (high potassium levels) is a potential risk; avoid potassium supplements, high-potassium foods, and salt substitutes unless directed by a physician

• Do not stop taking Cilnidipine even if blood pressure is controlled, as this may worsen hypertension

Technical Product Specification Table

Pharmaceutical distributors, hospitals, and healthcare organizations seeking a trusted Cilnidipine and Olmesartan Medoxomil Tablets (10mg+40mg) manufacturer & supplier in India can partner with Taj Pharma.

📞 Contact Taj Pharma Today to secure bulk supplies for your market.
🌍 Visit: www.tajpharma.com

Top 20 FAQs

Q1: What are these tablets used for?
A1: They are prescribed for managing hypertension (high blood pressure).

Q2: Who is the leading manufacturer in India?
A2: Taj Pharma, Vapi, Gujarat.

Q3: How do these tablets work?
A3: Cilnidipine relaxes blood vessels, and Olmesartan blocks angiotensin II to lower blood pressure.

Q4: Are there side effects?
A4: Dizziness, headaches, flu-like symptoms, gastrointestinal discomfort, edema, and UTIs.

Q5: Can these tablets cause kidney issues?
A5: Olmesartan may cause kidney damage; consult a healthcare provider immediately if symptoms appear.

Q6: Should potassium intake be limited?
A6: Yes, avoid potassium supplements, potassium-rich foods, and salt substitutes unless prescribed.

Q7: Can these tablets be combined with other anti-hypertensive drugs?
A7: Only under medical supervision; combination therapy may be required.

Q8: What is the shelf-life?
A8: 24–36 months, depending on storage conditions.

Q9: Are these tablets available for PCD Pharma Franchise?
A9: Yes, Taj Pharma provides nationwide PCD franchise options.

Q10: How are they packaged for export?
A10: Alu-Alu blister packs, HDPE bottles, and unit-dose packs with multi-lingual labeling.

Q11: Storage conditions?
A11: Store below 30°C, in a dry, cool place away from sunlight.

Q12: Are combination tablets more effective than monotherapy?
A12: Yes, they provide better blood pressure control than either drug alone.

Q13: Can pregnant women take these tablets?
A13: Consult a doctor; ARBs are generally avoided during pregnancy.

Q14: Do these tablets reduce cardiovascular risk?
A14: Yes, indirectly, by controlling hypertension.

Q15: Is Taj Pharma WHO-GMP certified?
A15: Yes, all manufacturing facilities comply with WHO-GMP standards.

Q16: How quickly do the tablets act?
A16: Blood pressure reduction may be seen within 2–4 weeks.

Q17: Food restrictions?
A17: Avoid high-potassium foods unless advised by a physician.

Q18: Can electrolyte imbalance occur?
A18: Yes, hyperkalemia is a possible risk.

Q19: Can these tablets be exported to regulated markets?
A19: Yes, including Europe, USA, Africa, Middle East, and Asia-Pacific.

Q20: Why choose Taj Pharma?
A20: Premium quality, WHO-GMP compliance, cost-effective pricing, and reliable global supply.